Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Raw Materials (2023 - 2025)

Historic Raw Materials for Evoke Pharma (EVOK) over the last 3 years, with Q3 2025 value amounting to $297864.0.

  • Evoke Pharma's Raw Materials rose 1569.02% to $297864.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $297864.0, marking a year-over-year increase of 1569.02%. This contributed to the annual value of $257467.0 for FY2024, which is 2872.27% down from last year.
  • Per Evoke Pharma's latest filing, its Raw Materials stood at $297864.0 for Q3 2025, which was up 1569.02% from $294601.0 recorded in Q2 2025.
  • Evoke Pharma's Raw Materials' 5-year high stood at $361219.0 during Q4 2023, with a 5-year trough of $157070.0 in Q1 2025.
  • Its 3-year average for Raw Materials is $274031.8, with a median of $283283.0 in 2024.
  • The largest annual percentage gain for Evoke Pharma's Raw Materials in the last 5 years was 1569.02% (2025), contrasted with its biggest fall of 4455.37% (2025).
  • Quarter analysis of 3 years shows Evoke Pharma's Raw Materials stood at $361219.0 in 2023, then decreased by 28.72% to $257467.0 in 2024, then increased by 15.69% to $297864.0 in 2025.
  • Its Raw Materials stands at $297864.0 for Q3 2025, versus $294601.0 for Q2 2025 and $157070.0 for Q1 2025.